Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Abeona Therapeutics Inc ABEO

Healthcare Biotechnology
Abeona Therapeutics Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in developing cell and gene therapies for life-threatening diseases. The Company’s lead clinical program is for prademagene zamikeracel (pz-cel), its investigational autologous, COL7A1 gene-corrected epidermal sheets currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The... see more

Recent & Breaking News (NDAQ:ABEO)

REGENXBIO and Abeona Therapeutics Announce Worldwide Exclusive Licenses for the Treatment of Four Rare Lysosomal Storage Disorders Using NAV AAV9 Vector

PR Newswire November 5, 2018

The Daily Biotech Pulse: AbbVie Takes Full Control Of Cystic Fibrosis Program, Amgen Slashes Cholesterol Drug Price

Benzinga.com  October 25, 2018

Abeona Therapeutics Appoints João Siffert, M.D. Head of Research and Development and Chief Medical Officer

GlobeNewswire October 18, 2018

Investor Expectations to Drive Momentum within Cincinnati Bell, Hooker Furniture, AgroFresh Solutions, Forward Industries, Abeona Therapeutics, and Sientra — Discovering Underlying Factors of Influence

GlobeNewswire October 16, 2018

The Daily Biotech Pulse: Clinical Hold Lifted Off Crispr's Gene-Edited Therapy, Endra To Offer Shares

Benzinga.com  October 11, 2018

Abeona Announces Participation at Upcoming Conferences

GlobeNewswire September 28, 2018

Abeona Therapeutics Announces Authorization to Commence Phase 1/2 Gene Therapy Clinical Study for Patients with MPS IIIB in Spain

GlobeNewswire September 12, 2018

Abeona Announces Participation at Upcoming Conferences

GlobeNewswire September 4, 2018

Abeona Therapeutics Reports Second Quarter 2018 Financial Results and Business Highlights

GlobeNewswire August 9, 2018

Abeona Therapeutics Announces Leadership Appointments with Max Colao as Chief Commercial Officer

GlobeNewswire July 26, 2018

Newman Ferrara LLP Announces Corporate Governance Investigation of Abeona Therapeutics Inc. – ABEO

Business Wire June 18, 2018

Abeona Therapeutics Announces Upcoming Presentation at Jefferies 2018 Global Healthcare Conference

GlobeNewswire June 6, 2018

Abeona Therapeutics Announces Opening of Commercial Gene & Cell Therapy Manufacturing Facility in Ohio

GlobeNewswire May 31, 2018

Abeona Therapeutics Provides Clinical Update on MPS IIIA Gene Therapy Trial at the 21st Annual ASGCT Meeting

GlobeNewswire May 18, 2018

Abeona Reports Update from EB-101 Gene Therapy in Epidermolysis Bullosa at 21st Annual ASGCT Meeting

GlobeNewswire May 17, 2018

Abeona Therapeutics Announces Appointment of Stefano Buono and Richard Van Duyne to its Board of Directors

GlobeNewswire May 14, 2018

Abeona Therapeutics Reports First Quarter 2018 Financial Results and Business Highlights

GlobeNewswire May 11, 2018

Abeona Therapeutics Announces Upcoming Presentations

GlobeNewswire May 8, 2018

Abeona Therapeutics Receives Orphan Drug Designation in the European Union for ABO-202 Gene Therapy Program in Batten Disease

GlobeNewswire April 20, 2018

Abeona Therapeutics Appoints Carsten Thiel, Ph.D., as Chief Executive Officer

GlobeNewswire April 2, 2018